港股异动 | 康希诺生物(06185)涨超5% 重组三价嵴髓灰质炎疫苗已获国家药监局批准开展临床试验
Last Update:
17 7 月, 2025
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.